SOL SPA (SOL.MI) Stock Overview
Europe - BIT:SOL - IT0001206769 - Common Stock
SOL.MI Key Statistics, Chart & Performance
The current stock price of SOL.MI is 52 EUR. In the past month the price increased by 2.16%. In the past year, price increased by 45.45%.
SOL.MI Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 1LINUS.MI | LINDE PLC | 28.43 | 183.16B | ||
| LIN.DE | LINDE PLC | 28.03 | 180.62B | ||
| AI.PA | AIR LIQUIDE SA | 27.49 | 99.72B | ||
| AIL.DE | AIR LIQUIDE SA | 27.49 | 99.73B | ||
| AP3.DE | AIR PRODUCTS & CHEMICALS INC | 20.72 | 48.47B |
Related stock screener links
About SOL.MI
Company Profile
SOL SpA engages in the production, research, and distribution of industrial and medicinal gases; door-to-door medical care; and related medical equipment. The company is headquartered in Monza, Monza E Brianza and currently employs 7,412 full-time employees. The company is also involved in the home care medical business. The Company’s product portfolio includes oxygen, nitrogen, hydrogen, argon, sulfur hexafluoride, carbon dioxide, ozone, helium and mixtures of medicinal gases, among others. Through its subsidiaries, the Company is involved in the provision of home care services, such as oxygen therapy, mechanical ventilation, diagnosis and care of obstructive sleep apnea syndrome, artificial nutrition, telemedicine, health assistance, and the prevention and treatment of skin ulcers. Additionally, it is engaged in the supply and management of medical and technological devices for home care. As of December 31, 2011, the Company had a number of subsidiaries, including Airsol BV, Biotechsol Srl, CTS Srl, Energetika ZJ doo, GTH Gaze Industriale SA, Cryolab Srl, GTS Shpk and Hydroenergy Shpk, among others.
Company Info
SOL SPA
Via Borgazzi, 27
Monza MONZA E BRIANZA IT
Employees: 7200
Phone: 3903923961
SOL SPA / SOL.MI FAQ
What does SOL do?
SOL SpA engages in the production, research, and distribution of industrial and medicinal gases; door-to-door medical care; and related medical equipment. The company is headquartered in Monza, Monza E Brianza and currently employs 7,412 full-time employees. The company is also involved in the home care medical business. The Company’s product portfolio includes oxygen, nitrogen, hydrogen, argon, sulfur hexafluoride, carbon dioxide, ozone, helium and mixtures of medicinal gases, among others. Through its subsidiaries, the Company is involved in the provision of home care services, such as oxygen therapy, mechanical ventilation, diagnosis and care of obstructive sleep apnea syndrome, artificial nutrition, telemedicine, health assistance, and the prevention and treatment of skin ulcers. Additionally, it is engaged in the supply and management of medical and technological devices for home care. As of December 31, 2011, the Company had a number of subsidiaries, including Airsol BV, Biotechsol Srl, CTS Srl, Energetika ZJ doo, GTH Gaze Industriale SA, Cryolab Srl, GTS Shpk and Hydroenergy Shpk, among others.
Can you provide the latest stock price for SOL SPA?
The current stock price of SOL.MI is 52 EUR. The price decreased by -0.38% in the last trading session.
Does SOL stock pay dividends?
SOL SPA (SOL.MI) has a dividend yield of 0.75%. The yearly dividend amount is currently 0.42.
How is the ChartMill rating for SOL SPA?
SOL.MI has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
How is the valuation of SOL SPA (SOL.MI) based on its PE ratio?
The PE ratio for SOL SPA (SOL.MI) is 30.23. This is based on the reported non-GAAP earnings per share of 1.72 and the current share price of 52 EUR.
Can you provide the upcoming earnings date for SOL SPA?
SOL SPA (SOL.MI) will report earnings on 2026-03-25, after the market close.
SOL.MI Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to SOL.MI. When comparing the yearly performance of all stocks, SOL.MI is one of the better performing stocks in the market, outperforming 81.64% of all stocks.
SOL.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to SOL.MI. SOL.MI has an excellent profitability rating, but there are some minor concerns on its financial health.
SOL.MI Financial Highlights
Over the last trailing twelve months SOL.MI reported a non-GAAP Earnings per Share(EPS) of 1.72. The EPS increased by 10.79% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 9.17% | ||
| ROA | 6.9% | ||
| ROE | 14.75% | ||
| Debt/Equity | 0.7 |
SOL.MI Forecast & Estimates
8 analysts have analysed SOL.MI and the average price target is 53.27 EUR. This implies a price increase of 2.44% is expected in the next year compared to the current price of 52.
For the next year, analysts expect an EPS growth of 12.17% and a revenue growth 11.34% for SOL.MI